Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-121
Closed -$1.6K – 1096
2025
Q3
$1.6K Buy
+121
New +$1.56K ﹤0.01% 950
2018
Q4
– Sell
-5,449
Closed -$235K – 309
2018
Q3
$235K Hold
5,449
– – 0.02% 299
2018
Q2
$236K Hold
5,449
– – 0.02% 259
2018
Q1
$201K Buy
+5,449
New +$200K 0.02% 271
2017
Q4
– Sell
-8,058
Closed -$288K – 273
2017
Q3
$288K Sell
8,058
-5,342
-40% -$174K 0.03% 221
2017
Q2
$441K Sell
13,400
-16,756
-56% -$578K 0.05% 189
2017
Q1
$1.21M Buy
30,156
+16,073
+114% +$626K 0.14% 139
2016
Q4
$527K Buy
14,083
+784
+6% +$28.6K 0.06% 177
2016
Q3
$489K Sell
13,299
-103,566
-89% -$3.48M 0.06% 178
2016
Q2
$3.93M Buy
+116,865
New +$3.75M 0.52% 66

Other funds holding NOV

Montag & Associates's NOV Position: Q4 2025 in Review

Montag & Associates sold out of NOV (NOV) in Q4 2025, closing a stake of 121 shares — an estimated $1.6K sold.

Montag & Associates first reported a position in NOV in Q2 2016 and held it in 10 quarters. The position peaked at $3.93M in Q2 2016. 434 funds tracked by Wall St. Rank hold NOV as of Q4 2025.

  • Montag & Associates reported no remaining NOV position as of Q4 2025 after selling out during the quarter.
  • Montag & Associates sold 121 NOV shares in Q4 2025, an estimated $1.6K.
  • Montag & Associates first reported a position in NOV in Q2 2016 and held it in 10 quarters.
  • Montag & Associates's NOV position peaked at $3.93M in Q2 2016.
  • 434 funds tracked by Wall St. Rank held NOV as of Q4 2025.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.